HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 4, 2010, Pages

  Feinman, Rena ^a   Deitch, Edwin A ^a   Watkins, Anthony C ^a   Abungu, Billy ^a   Colorado, Iriana ^a   Kannan, Kolenkode B ^a   Sheth, Sharvil U ^a   Caputo, Francis J ^a   Lu, Qi ^a   Ramanathan, Madhuri ^a   Attan, Shirhan ^a   Badami, Chirag D ^a   Doucet, Danielle ^a   Barlos, Dimitrios ^a   Bosch Marce, Marta ^b   Semenza, Gregg L ^b   Xu, Da Zhong ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute lung injury; Hemorrhagic shock; Inflammation; Multiple organ dysfunction syndrome

Indexed keywords

CASPASE 3; CYCLOOXYGENASE 2; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HIF1A PROTEIN, MOUSE;

ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; ENZYME ACTIVATION; HEMORRHAGIC SHOCK; ILEUM MUCOSA; IN VIVO STUDY; INFLAMMATION; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; LUNG INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; ANIMAL; APOPTOSIS; ENTEROPATHY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; INTESTINE; INTESTINE MUCOSA; LUNG; METABOLISM; PATHOLOGY; PERMEABILITY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CYTOKINES; GENE EXPRESSION REGULATION; GENOTYPE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INTESTINAL DISEASES; INTESTINAL MUCOSA; INTESTINES; LUNG; LUNG INJURY; MICE; PERMEABILITY; REPERFUSION INJURY; RNA, MESSENGER; SHOCK, HEMORRHAGIC;

EID: 77957372870     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00065.2010     Document Type: Article

References (74)

1. Bakker WJ, Harris IS, Mak TW. FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol Cell 28: 941-953, 2007.
2. Baregamian N, Rychahou PG, Hawkins HK, Evers BM, Chung DH. Phosphatidylinositol 3-kinase pathway regulates hypoxia-inducible factor- 1 to protect from intestinal injury during necrotizing enterocolitis. Surgery 142: 295-302, 2007.
3. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 48: 285-296, 2000.
4. Bernaudin M, Nedelec A, Divoux D, MacKenzie E, Petit E, Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22: 393-403, 2002. (Pubitemid 34273595)
5. Bosch-Marce M, Okuyama H, Wesley J, Sarkar K, Kimura H, Liu Y, Zhang H, Strazza M, Rey S, Savino L, Zhou Y, McDonald K, Na Y, Vandiver S, Rabi A, Shaked Y, Kerbel R, LaVallee T, Semenza G. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 101: 1310-1318, 2007.
6. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, Trush MA, Semenza GL. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1α. Cardiovasc Res 77: 463-470, 2008.
7. Chaitanya GV, Babu PP. Activation of calpain, cathepsin-B and caspase-3 during transient focal cerebral ischemia in rat model. Neurochem Res 33: 2178-2186, 2008.
8. Chen C, Hu Q, Yan J, Yang X, Shi X, Lei J, Chen L, Huang H, Han J, Zhang JH, Zhou C. Early inhibition of HIF-1α with small interfering RNA reduces ischemic-reperfused brain injury in rats. Neurobiol Dis 33: 509-517, 2009.
9. Chiu C, McArdle A, Brown R, Scott H, Gurd F. Intestinal mucosal lesions in low-flow states. Arch Surg 101: 478-483, 1970.
10. Claridge JA, Enelow RI, Young JS. Hemorrhage and resuscitation induce delayed inflammation and pulmonary dysfunction in mice. J Surg Res 92: 206-213, 2000.
11. Clark JA, Coopersmith CM. Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28: 384-393, 2007.
12. Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134: 156-165, 2008.
13. Dehne N, Brüne B. HIF-1 in the inflammatory microenvironment. Exp Cell Res 315: 1791-1797, 2009.
14. Deitch E, Xu DZ, Franko L, Ayala A, Chaudry I. Evidence favoring the role of the gut as a cytokine generating organ in rats subjected to hemorrhagic shock. Shock 1: 141-146, 1994.
15. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock 9: 1-11, 1998.
16. Deitch EA. Multiple organ failure: pathophysiology and potential future therapy. Ann Surg 216: 117-134, 1992.
17. Deitch EA, Berg R, RS. Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 122: 185-190, 1987. (Pubitemid 17007181)
18. Deitch EA, Sambol JT. The gut origin hypothesis of MODS. In: Sepsis and Multiple Organ Dysfunction: A Multidisciplinary Approach, edited by Deitch EA, Vincent J-L, Windsor A. Philadelphia, PA: Saunders, 2002, p. 105-116.
19. Deitch EA, Xu D, Lu Q. Gut lymph hypothesis of early shock and trauma-induced multiple organ dysfunction: a new look at gut origin of sepsis. J Org Dys 2: 70-70, 2006.
20. Dhanasekaran A, Gruenloh SK, Buonaccorsi JN, Zhang R, Gross GJ, Falck JR, Patel PK, Jacobs ER, Medhora M. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am J Physiol Heart Circ Physiol 294: H724-H735, 2008. (Pubitemid 351253284)
21. Fink MP, Delude RL. Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin 21: 177-196, 2005.
22. Forsythe RM, Xu DZ, QL, Deitch EA. LPS-induced enterocyte-derived nitric oxide induces intestinal monolayer permeability in an autocrine fashion. Shock 17: 180-184, 2002.
23. Fraisl P, Aragones J, Carmeliet P. Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 8: 139-152, 2009.
24. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193: 1027-1034, 2001.
25. Giakoustidis AE, Giakoustidis DE, Koliakou K, Kaldrymidou E, Iliadis S, Antoniadis N, Kontos N, Papanikolaou V, Papageorgiou G, Atmatzidis K, Takoudis D. Inhibition of intestinal ischemia/reperfusion induced apoptosis and necrosis via down-regulation of the NF-kB, c-Jun and caspase-3 expression by epigallocatechin-3-gallate administration. Free Radic Res 42: 180-188, 2008.
26. Greijer A, van der Wall E. The role of hypoxia inducible factor (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 57: 1009-1014, 2004.
27. Hart ML, Henn M, Kohler D, Kloor D, Mittelbronn M, Gorzolla IC, Stahl GL, Eltzschig HK. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 22: 2784-2797, 2008.
28. Hartmann H, Eltzschig HK, Wurz H, Hantke K, Rakin A, Yazdi AS, Matteoli G, Bohn E, Autenrieth IB, Karhausen J, Neumann D, Colgan SP, Kempf VAJ. Hypoxia-independent activation of HIF-1 by Enterobacteriaceae and their siderophores. Gastroenterology 134: 756-767, 2008.
29. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561-1567, 1999. (Pubitemid 29411306)
30. Helton R, Cui J, Scheel JR, Ellison JA, Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, Johnson RS, Lipton SA, Barlow C. Brain-specific knock-out of hypoxia-inducible factor-1α reduces rather than increases hypoxic-ischemic damage. J Neurosci 25: 4099-4107, 2005. (Pubitemid 40563385)
31. Hierholzer C, Harbrecht BG, Billiar TR, Tweardy DJ. Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events. Arch Orthop Trauma Surg 121: 219-222, 2001.
32. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-7992, 1998.
33. Inoue K, Takahashi T, Uehara K, Shimuzu H, Ido K, Morimatsu H, Omori E, Katayama H, Akagi R, KM. Protective role of heme oxygenase 1 in the intestinal tissue injury in hemorrhagic shock in rats. Shock 29: 252-261, 2008.
34. 2 sensing. Science 292: 464-468, 2001.
35. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12: 149-162, 1998.
36. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
37. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114: 1098-1106, 2004. (Pubitemid 39578699)
38. Kawagoe T, Sato S, Jung A, Yamamoto M, Matsui K, Kato H, Uematsu S, Takeuchi O, Akira S. Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J Exp Med 204: 1013-1024, 2007.
39. Kiang JG, Bowman PD, Lu X, Li Y, Wu BW, Loh HH, Tsen KT, Tsokos GC. Geldanamycin inhibits hemorrhage-induced increases in caspase-3 activity: role of inducible nitric oxide synthase. J Appl Physiol 103: 1045-1055, 2007.
40. Kiang JG, Peckham RM, Duke LE, Shimizu T, Chaudry IH, Tsokos GC. Androstenediol inhibits the trauma-hemorrhage-induced increase in caspase-3 by downregulating the inducible nitric oxide synthase pathway. J Appl Physiol 102: 933-941, 2007. (Pubitemid 46377015)
41. Koury J, Deitch EA, Homma H, Abungu B, Gangurde P, Condon MR, Lu Q, Xu DZ, RF. Persistent HIF-1α activation in gut ischemia/reperfusion injury: potential role of bacteria and lipopolysaccharide. Shock 22: 270-277, 2004. (Pubitemid 39468993)
42. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16: 1466-1471, 2002. (Pubitemid 34686328)
43. Lei L, Mason S, Liu D, Huang Y, Marks C, Hickey R, Jovin IS, Pypaert M, Johnson RS, Giordano FJ. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol Cell Biol 28: 3790-3803, 2008.
44. Liaudet L, Szabo A, Soriano F, Zingarelli B, Szabo C, Salzman A. Poly(ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 14: 142-143, 2000.
45. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ 15: 686-690, 2008.
46. Madsen KL, Malfair D, Gray D, Doyle JS, Jewell LD, Fedorak RN. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis 5: 262-270, 1999.
47. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686, 2001. (Pubitemid 32988878)
48. Michalsky MP, Deitch EA, Ding J, Lu Q, Huang Q. Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli. Shock 7: 139-146, 1997. (Pubitemid 127654260)
49. Murao Y, Loomis W, Wolf P, Hoyt DB, Junger WG. Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock. Shock 20: 29-34, 2003.
50. Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9: 609-617, 2009.
51. Patel NJ, Zaborina O, Wu L, Wang Y, Wolfgeher DJ, Valuckaite V, Ciancio MJ, Kohler JE, Shevchenko O, Colgan SP, Chang EB, Turner JR, Alverdy JC. Recognition of intestinal epithelial HIF-1α activation by Pseudomonas aeruginosa. Am J Physiol Gastrointest Liver Physiol 292: G134-G142, 2007.
52. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR. Heterozygous HIF1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577: 705-716, 2006.
53. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V. Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J Immunol 178: 7516-7519, 2007. (Pubitemid 46898018)
54. Pfaffl M. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45, 2001.
55. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34: 1981-1986, 2003.
56. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP. Mucosal protection by hypoxia-inducible factor (HIF) prolyl hydroxylase inhibition. Gastroenterology 134: 144-155, 2008. (Pubitemid 350309309)
57. Rupani B, Caputo F, Watkins A, Vega D, Magnotti L, Lu Q, Xu D, Deitch E. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery 141: 481-489, 2007.
58. Scharte M, Han X, Bertges DJ, Fink MP, Delude RL. Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol Gastrointest Liver Physiol 284: G373-G384, 2003. (Pubitemid 36227885)
59. Scharte M, Han X, Uchiyama T, Tawadrous Z, Delude RL, Fink MP. LPS Increases hepatic HIF-1α protein and expression of the HIF-1- dependent gene aldolase A in rats. J Surg Res 135: 262-267, 2006.
60. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 91: 803-806, 2006.
61. Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134: 2036-2048, 2008.
62. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 20: 495-549, 2002.
63. Sutton TA, Wilkinson J, Mang HE, Knipe NL, Plotkin Z, Hosein M, Zak K, Wittenborn J, Dagher PC. p53 regulates renal expression of HIF-1α and pVHL under physiological conditions and after ischemia-reperfusion injury. Am J Physiol Renal Physiol 295: F1666-F1677, 2008.
64. Thuijls G, de Haan J, Derikx J, Daissormont I, Hadfoune M, Heineman E, Buurman W. Intestinal cytoskeleton degradation precedes tight junction loss following hemorrhagic shock. Shock 31: 164-169, 2009.
65. Van Hoecke M, Pringent-Tessier A, Garnier P, Bertrand N, Filomenko R, Bettaieb A, Marie C, Beley A. Evidence of HIF-1 functional binding activity to caspase-3 promoter after photothrombotic cerebral ischemia. Mol Cell Neurosci 34: 40-47, 2007. (Pubitemid 46026929)
66. Vangeison G, Carr D, Federoff HJ, Rempe DA. The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1α in neurons and astrocytes. J Neurosci 28: 1988-1993, 2008.
67. Wang GL, Semenza GL. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268: 21513-21518, 1993. (Pubitemid 23320639)
68. Wang Q, Fang CH, Hasselgren PO. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281: R1013-R1023, 2001. (Pubitemid 32885118)
69. Xu DZ, Lu Q, Guillory D, Cruz N, Berg R, Deitch EA. Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 34: 676-683, 1993. (Pubitemid 23171834)
70. Yang R, Gallo DJ, Baust JJ, Watkins SK, Delude RL, Fink MP. Effect of hemorrhagic shock on gut barrier function and expression of stress-related genes in normal and gnotobiotic mice. Am J Physiol Regul Integr Comp Physiol 283: R1263-R1274, 2002.
71. Yang R, Han X, Uchiyama T, Watkins SK, Yaguchi A, Delude RL, Fink MP. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 285: G621-G629, 2003.
72. Yeh KY, Yeh M, Glass J, Granger DN. Rapid activation of NF-kappaB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology 118: 525-534, 2000. (Pubitemid 30140850)
73. Yu HP, Hsieh YC, Suzuki T, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH. Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: upregulation of the PI-3K/Akt pathway. J Leukoc Biol 82: 774-780, 2007.
74. Zhang HY, Radulescu A, Besner GE. Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice. Surgery 146: 334-339, 2009.